外科医生报酬与关节置换患者复杂度的当前关系:2019年向医疗保险计费的所有初次关节置换的风险-支付分析
该研究利用2019年医疗保险医生及其他提供者文件,分析441,584例向Medicare Part B计费的初次全髋和全膝关节置换术。将患者按HCC风险评分≥1.5和<1.5分为两组,比较外科医生平均报酬。结果显示病情较重队列的平均报酬为1,059.21美元,低于较健康队列的1,073.32美元(P = .032)。
要点
- 2019年向Medicare Part B计费的初次全髋和全膝关节置换术共441,584例。
- HCC风险评分≥1.5的较病重队列平均报酬为1,059.21美元,低于HCC风险评分<1.5队列的1,073.32美元(P = .032)。
- 所有手术的平均报酬为1,068.03美元。
核心结论
- 在2019年接受初次全关节置换术的Medicare患者中,病情较重患者的外科医生平均报酬低于较健康患者,尽管这种差异的影响难以确定。
研究设计与样本
- 使用2019年医疗保险医生及其他提供者文件,纳入2019年向Medicare Part B计费的441,584例初次全髋和全膝关节置换术,收集所有患者的人口学和合并症特征、平均HCC风险评分和医生报酬,按HCC风险评分≥1.5和<1.5分为两组进行比较。
主要发现
- 所有手术的平均报酬为1,068.03美元。
- HCC风险评分≥1.5的较病重队列平均报酬为1,059.21美元,HCC风险评分<1.5队列为1,073.32美元(P = .032)。
- HCC风险评分≥1.5的较病重队列所有合并症发生率显著高于HCC风险评分<1.5队列。
临床怎么用
- 作者认为,随着替代支付模式的持续评估和开发,这些数据对于关节置换护理中更公平报酬模式的潜在进展很重要,特别是关于外科医生报酬和此类模式中可能的风险调整。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to assess surgeon reimbursement among total joint arthroplasty (TJA) patients who had differing risk profiles within the Medicare population. METHODS: The "2019 Medicare Physician and Other Provider" file was utilized. In 2019, 441,584 primary total hip and knee arthroplasty procedures were billed to Medicare Part B. All episodes were included. Patient demographics and comorbidity profiles were collected for all patients. Additionally, mean patient hierarchal condition category (HCC) risk scores and physician reimbursements were collected. All procedure episodes were split into 2 cohorts; those with an HCC risk score of 1.5 or greater, and those with patient HCC risk scores less than 1.5. Variables were averaged for each cohort and compared. RESULTS: The mean reimbursement across all procedures was $1,068.03. For the sicker patient cohort with a mean HCC risk score of 1.5 or greater, there was a significantly higher rate of all comorbidities compared to the cohort with HCC risk score under 1.5. The mean payment across the sicker cohort was $1,059.21, while the mean payment among the cohort with HCC risk score under 1.5 was 1,073.32 (P = .032). CONCLUSION: This study demonstrates that for Medicare patients undergoing primary TJA in 2019, the mean surgeon reimbursement was lower for primary TJA among sick patients in comparison to their healthier counterparts, although it is difficult to ascertain the impact of this discrepancy. As alternative payment models continue to undergo evaluation and development, these data will be important for the potential advancement of more equitable reimbursement models in arthroplasty care, specifically regarding surgeon reimbursement and possible risk adjustment within such models.
引用
- Haglin JM, Brinkman JC, Moore ML, et al. The Current Relationship Between Surgeon Reimbursement and Patient Complexity in Arthroplasty-A Risk-Payment Analysis of All Primary Joint Replacements Billed to Medicare in 2019. J Arthroplasty. 2023. PMID: 36828053. doi:10.1016/j.arth.2023.02.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。